Clinical Trial: A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants

U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07566130) titled 'A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants' on April 29.

Brief Summary: The objectives for this 2 Part study are to assess the safety, tolerability, and pharmacokinetics following single ascending oral doses of nacresertib in healthy adult participants (Part 1) and to assess the safety, tolerability, and pharmacokinetics following multiple ascending oral doses in healthy adult participants (Part 2).

Study Start Date: April 18, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: nacresertib...